. Author manuscript; available in PMC: 2018 Apr 7.

Published in final edited form as: J Proteome Res. 2017 Mar 8;16(4):1763–1772. doi: 10.1021/acs.jproteome.7b00024

Table 1. Differentially Expressed Exosomal Proteins during Treatments^a.

Accession	Abbreviation	normalized log2(T2/Tl)		normalized log2(T3/Tl)		normalized log2(T3/T2)		normalized log2(T0/Tl)
Accession	Abbreviation	p	Mean	p	Mean	p	Mean	p	Mean
P02786	CD71	0.013	0.733	0.022	0.458	0.107	-0.351	0.063	0.227
O75147	OBSL1	0.017	0.800	0.010	1.357	0.153	0.494	0.001	2.451
P02776	PLF4	0.020	1.125	0.007	0.853	0.752	-0.141	0.025	-0.769
PI8464	1B51	0.020	-0.955	0.784	-0.113	0.116	0.600	0.321	-0.745
P08670	Vimentin	0.108	-1.346	0.039	-0.854	0.301	0.497	0.729	-0.132
P61626	LYSC	0.562	-0.177	0.025	-0.644	0.268	-0.437	0.069	-0.625
Q9HBI1	PARVB	0.367	0.287	0.449	-0.189	0.007	-0.660	0.007	-0.536
Q15555	MARE2	0.638	0.296	0.293	-0.441	0.004	-1.029	0.005	-0.932

Red and blue represent up-regulated and down-regulated, respectively. Green indicates p value <0.05. The mean is labeled in bold if its p value is <0.05.

Table 1. Differentially Expressed Exosomal Proteins during Treatmentsa.

Table 1. Differentially Expressed Exosomal Proteins during Treatments^a.